By Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this information sheet, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this information sheet.
Company name : Hua Xia Healthcare Holdings Limited*
Stock code (ordinary shares) : 8143
This information sheet contains certain particulars concerning the above company (the "Company") which is listed on the Growth Enterprise Market ("GEM") of the Stock Exchange of Hong Kong Limited (the "Exchange"). These particulars are provided for the purpose of giving information to the public with regard to the Company in compliance with the Rules Governing the Listing of Securities on the Growth Enterprise Market of The Stock Exchange of Hong Kong Limited (the "GEM Listing Rules"). They will be displayed at the GEM website on the Internet. This information sheet does not purport to be a complete summary of information relevant to the Company and/or its securities.
The information in this sheet was updated as of 3 January 2014.
Wong Ka Wai, Jeanne - Independent non-executive
1
Names of substantial shareholders
(as such term is defined in rule 1.01 of the GEM Listing Rules) and their respective interests in the ordinary
shares and other securities of the Company
:
Marshal International
Investments Limited** Easeglory Holdings Limited** Yung Kwok Leong* (Note) Yung Muk Ying*** (Note)
Name(s) of company(ies) listed on
GEM or the Main Board of the
Stock Exchange within the
same group as the Company
* By reason of their controlling of Marshal International
Investments Limited and Easeglory Holdings Limited
** Beneficial owner
*** Interest of spouse
Note: Inclusive of interest in 602,701,680 unlisted convertible preference shares and 1,700,000 share options
: Wanjia Group Holdings Limited, an exempted company incorporated with limited liability in the Cayman Islands on 9 July 2012, and will be listed on the Main Board of The Stock Exchange of Hong Kong Limited on 11 October 2013 (stock code: 401)
Financial year end date : 31 March
Registered address : Cricket Square, Hutchins Drive,
P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands
Head office and principal
place of business
: 19/F, New Wing,
101 King's Road, Hong Kong
Web-site address : www.huaxia-healthcare.com
Share registrar : Principal share registrar and transfer office:
Royal Bank of Canada Trust Company (Cayman) Limited
4th Floor, Royal Bank House
24 Shedden Road, George Town
Grand Cayman KY1-1110
Cayman Islands
Hong Kong branch share registrar and transfer office:
Tricor Tengis Limited
26th Floor, Tesbury Centre,
28 Queen's Road East, Wanchai, Hong Kong
2
Auditors : HLB Hodgson Impey Cheng Limited
Chartered Accountants
Certified Public Accountants
The Company acts as an investment holding company while its subsidiaries are principally engaged in the pharmaceutical wholesale and distribution and pharmaceutical retail chain businesses, provision of general hospital and healthcare and hospital management services in the PRC.
C. Ordinary shares
Number of ordinary shares
in issue
: 1,150,838,264
Par value of ordinary shares
in issue
: HK$0.01
Board lot size (in number of
shares)
: 4,000 shares
Name of other stock exchange(s)
on which ordinary shares are also listed
: Nil
Not applicable
E. Other securities
Number of unlisted convertible
preference shares in issue
: 602,701,680
Par value of unlisted convertible
preference share in issue
: HK$0.01
Number of share options granted
and outstanding
: 44,051,287
Number of conversion shares outstanding from the unlisted
convertible notes
: 3,421,053
3
Responsibility statement
The directors of the Company (the "Directors") as at the date hereof hereby collectively and individually accept full responsibility for the accuracy of the information contained in this information sheet (the "Information") and confirm, having made all reasonable inquiries, that to the best of their knowledge and belief the Information is accurate and complete in all material respects and not misleading and that there are no other matters the omission of which would make any Information inaccurate or misleading.
The Directors also collectively and individually accept full responsibility for submitting a revised information sheet, as soon as reasonably practicable after any particulars on the form previously published cease to be accurate.
The Directors acknowledge that the Stock Exchange has no responsibility whatsoever with regard to the Information and undertake to indemnify the Exchange against all liability incurred and all losses suffered by the Exchange in connection with or relating to the Information.
Signed:
Yung Kwok Leong Chen Jin Shan
Jiang Tao Wong Yu Man, James
Wong Ka Wai, Jeanne Zheng Gang
Hu Shanlian Huang Jiaqing
Lu Chuanzhen
4
|
distributed by
|
